The Effect of Lyophilized and Frozen Umbilical Cord Cryoextract on L929 Cell Culture

Authors

DOI:

https://doi.org/10.20535/ibb.2025.9.1.313718

Abstract

Background. The human umbilical cord is a promising source of biologically active substances with regenerative properties. However, the potential of lyophilized cryoextract from the umbilical cord for regenerative medicine, which could facilitate storage and transportation, remains unexplored. Therefore, it is important to study the effect of such cryoextracts using a cellular model.

Objective. To evaluate the effect of lyophilized and frozen umbilical cord cryoextracts on the L929 cell line to assess their therapeutic potential.

Methods. This study was conducted on L929 cell cultures. Cryoextracts from the human umbilical cord were obtained through cryoextraction and lyophilized forms at -80 and -20 °C. These extracts were added to Dulbecco's Modified Eagle Medium (DMEM) at three concentrations: 0.1, 0.5, and 1.0 mg/ml. The control groups included cells cultured in DMEM with and without fetal bovine serum. Cell morphology and monolayer confluency were observed. To assess the impact of the cryoextracts, several assays were performed: cell viability (adhesion), migration activity (scratch test), pinocytosis activity (neutral red uptake assay), metabolic activity (MTT assay), and (proliferation) population doubling time.

Results. The addition of umbilical cord cryoextract and its lyophilized form at -80 °C was non-toxic to the cells. The most effective concentration was 0.1 mg/ml, which significantly stimulated cell adhesion and proliferation compared to the culture medium without fetal serum. The lyophilized cryoextract at -20 °C did not enhance cell viability but did increase pinocytosis activity.

Conclusions. These findings suggest that umbilical cord cryoextract and its lyophilized form at -80 °C can be used as growth factors in cell line cultivation. The lyophilized cryoextract shows promise for use in conditions where specialized storage equipment is not available. However, the lyophilized form at -20 °C primarily stimulates pinocytosis activity and inhibits proliferation.

References

Fathi AH, Soltanian H, Saber AA. Surgical anatomy and morphologic variations of umbilical structures. Am Surg. 2012 May;78(5):540-4. DOI: 10.1177/000313481207800534

Davies JE, Walker JT, Keating A. Concise review: Wharton's jelly: the rich, but enigmatic, source of mesenchymal stromal cells. Stem Cells Transl Med. 2017 Jul;6(7):1620-30. DOI: 10.1002/sctm.16-0492

Basta M, Lipsett BJ. Anatomy, abdomen and pelvis: umbilical cord. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Oct 7]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519586/

Li W, Ye B, Cai XY, Lin JH, Gao WQ. Differentiation of human umbilical cord mesenchymal stem cells into prostate-like epithelial cells in vivo. PLoS One. 2014 Jul 23;9(7). DOI: 10.1371/journal.pone.0102657

Chen KH, Shao PL, Li YC, Chiang JY, Sung PH, Chien HW, et al. Human umbilical cord-derived mesenchymal stem cell therapy effectively protected the brain architecture and neurological function in rat after acute traumatic brain injury. Cell Transplant. 2020 Jan-Dec;29:963689720929313. DOI: 10.1177/0963689720929313

Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2018 Jan;93(1):19-31. DOI: 10.1002/cyto.a.23242

Hong B, Lee S, Shin N, Ko Y, Kim D, Lee J, Lee W. Bone regeneration with umbilical cord blood mesenchymal stem cells in femoral defects of ovariectomized rats. Osteoporos Sarcopenia. 2018 Sep;4(3):95-101. DOI: 10.1016/j.afos.2018.08.003

Sun X, Hao H, Han Q, Song X, Liu J, Dong L, Han W, Mu Y. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther. 2017 Nov 2;8(1):241. DOI: 10.1186/s13287-017-0668-1

Chez M, Lepage C, Parise C, Dang-Chu A, Hankins A, Carroll M. Safety and observations from a placebo-controlled, crossover study to assess use of autologous umbilical cord blood stem cells to improve symptoms in children with autism. Stem Cells Transl Med. 2018 Apr;7(4):333-41. DOI: 10.1002/sctm.17-0042

Galieva LR, Mukhamedshina YO, Arkhipova SS, Rizvanov AA. Human umbilical cord blood cell transplantation in neuro¬regenerative strategies. Front Pharmacol. 2017 Sep 8;8:628. DOI: 10.3389/fphar.2017.00628

Ward KR, Matejtschuk P. The principles of freeze-drying and application of analytical technologies. Methods Mol Biol. 2021;2180:99-127. DOI: 10.1007/978-1-0716-0783-1_3

Akers MJ. Basic principles of lyophilization, part 1. Int J Pharm Compd. 2015 Nov-Dec;19(6):471-6.

Bullard JD, Lei J, Lim JJ, Massee M, Fallon AM, Koob TJ. Evaluation of dehydrated human umbilical cord biological properties for wound care and soft tissue healing. J Biomed Mater Res B Appl Biomater. 2019 May;107(4):1035-46. DOI: 10.1002/jbm.b.34196

Couture M. A single-center, retrospective study of cryopreserved umbilical cord for wound healing in patients suffering from chronic wounds of the foot and ankle. Wounds. 2016 Jul;28(7):217-25.

Liu Q, Barragan HR, Matcham G. Umbilical cord biomaterial for medical use. WO patent WO2008021391A1. 2008 Feb 21. Available from: https://patents.google.com/patent/WO2008021391A1/en?oq=WO2008021391A1

Kim SM, Moon SH, Lee Y, Kim GJ, Chung HM, Choi YS. Alternative xeno-free biomaterials derived from human umbilical cord for the self-renewal ex-vivo expansion of mesenchymal stem cells. Stem Cells Dev. 2013 Nov 15;22(22):3025-38. DOI: 10.1089/scd.2013.0067

Yildiz H, Sen E, Dalcik H, Meseli SE. Evaluation of cell morphology and adhesion capacity of human gingival fibroblasts on titanium discs with different roughened surfaces: an in vitro scanning electron microscope analysis and cell culture study. Folia Morphol (Warsz). 2023;82(1):63-71. DOI: 10.5603/FM.a2022.0072

Hulkower KI, Herber RL. Cell migration and invasion assays as tools for drug discovery. Pharmaceutics. 2011 Mar 11;3(1):107-24. DOI: 10.3390/pharmaceutics3010107

Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc. 2008;3(7):1125-31. DOI: 10.1038/nprot.2008.75

Culenova M, Nicodemou A, Novakova ZV, Debreova M, Smolinská V, Bernatova S, et al. Isolation, culture and compre-hensive characterization of biological properties of human urine-derived stem cells. Int J Mol Sci. 2021 Nov 19;22(22):12503. DOI: 10.3390/ijms222212503

Priyadarshini P, Samuel S, Kurkalli BG, Kumar C, Kumar BM, Shetty N, et al. In vitro comparison of adipogenic differentiation in human adipose-derived stem cells cultured with collagen gel and platelet-rich fibrin. Indian J Plast Surg. 2021 Aug 26;54(3):278-83. DOI: 10.1055/s-0041-1733810

Sukhodub L, Kumeda M, Sukhodub L, Tsyndrenko O, Petrenko O, Prokopiuk V, et al. The effect of carbon and magnetic nanoparticles on the properties of chitosan-based neural tubes: Cytotoxicity, drug release, In Vivo nerve regeneration. Carbohydr Polym Technol Appl. 2024;8:100528. DOI: 10.1016/j.carpta.2024.100528

Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003;21(1):105-10. DOI: 10.1634/stemcells.21-1-105

Velarde F, Castañeda V, Morales E, Ortega M, Ocaña E, Álvarez-Barreto J, et al. Use of human umbilical cord and its byproducts in tissue regeneration. Front Bioeng Biotechnol. 2020 Mar 10;8:117. DOI: 10.3389/fbioe.2020.00117

Raphael A. A single-centre, retrospective study of cryopreserved umbilical cord/amniotic membrane tissue for the treatment of diabetic foot ulcers. J Wound Care. 2016 Jul 1;25(Sup7). DOI: 10.12968/jowc.2016.25.Sup7.S10

Chang HK, Lo WY. Cryopreservation of umbilical cord tissue for cord tissue-derived stem cells. US patent US8703411B2. 2014 Apr 22. Available from: https://patents.google.com/patent/US8703411B2/en

Caputo WJ, Vaquero C, Monterosa A, Monterosa P, Johnson E, Beggs D, et al. A retrospective study of cryopreserved umbilical cord as an adjunctive therapy to promote the healing of chronic, complex foot ulcers with underlying osteomyelitis. Wound Repair Regen. 2016 Sep;24(5):885-93. DOI: 10.1111/wrr.12456

Raphael A, Gonzales J. Use of cryopreserved umbilical cord with negative pressure wound therapy for complex diabetic ulcers with osteomyelitis. J Wound Care. 2017 Oct 1;26(Sup10). DOI: 10.12968/jowc.2017.26.Sup10.S38

Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018 Jan;1411(1):153-65. DOI: 10.1111/nyas.13569

Marston WA, Lantis JC 2nd, Wu SC, Nouvong A, Lee TD, McCoy ND, et al. An open-label trial of cryopreserved human umbilical cord in the treatment of complex diabetic foot ulcers complicated by osteomyelitis. Wound Repair Regen. 2019 Nov;27(6):680-6. DOI: 10.1111/wrr.12754

Downloads

Published

2025-01-30

How to Cite

1.
Kaverinska A, Shevchenko N, Osetsky A, Sukhodub L, Lazurenko V, Zhelezniakov O, Prokopiuk V. The Effect of Lyophilized and Frozen Umbilical Cord Cryoextract on L929 Cell Culture. Innov Biosyst Bioeng [Internet]. 2025Jan.30 [cited 2025Feb.10];9(1):3-12. Available from: https://ibb.kpi.ua/article/view/313718